Agenda for Action West Nile Virus: Emerging Threat to Public Health and Animal Health
West Nile virus (WNVj is ul the genus FLa;,iu~riii, family Flavioiridae, and is closely related to other members of this genus: Japanese encephalitis virus in Southeast I s i a , Murray Valley encephalitis virus in Australia, and St. Louis encephalitis (SLE) rirus in North and South America. The principal vertebrate hosts for these artluopod-borne 1-iruses (arbovirusesj are wild birds, and the primary vectors are mosquitoes. Little clinical disease or mortality has been reported previously in xvild birds from natural infection with these viruses, although signdicant morbidity and mortality has occurred in humans and domestic animals. West Kile virus (WNV) previously occurred throughout .4frica, Middie East, Europe, and the western parts of .4sia and was introduced into the United States in New York City (XYC) in 1999. It is still unknoxun how WhT' entered the E5, but lt quickly became established, causing a human epidemic ot 62 cases and an epizootic in the regional bird population, mostly in American crows. 'The IVY\; strain introduced ivas virulent for North m e r i c a n birds and caused sipificant mortality in cro~vs and related species. This bird mortality was unusual for arboviruses but quickly became a useful sentinel for public health officials to detect the presence of M'KV.
hlullistate surveillance was established in 2000 in the Atldntic and Gulf coastal states by the Centers for Disease Control and Prevention (CDC) to track possible WNT' espanslon from the affected area in the northeast and was expanded nationwide in 2001 Components of the surveillance network included dead bird surveillance (virus testing of dead wild birds), monitoring serologic conversions in sentlnel chickens, mosquito momtoring and testing, and enhanced passive veterinary and human s u n eillance. Advanced virus/antigen detection systems (polymerase chain reaction, PCR) provided rapid testing of birds and mosquitoes ~n d aided in tracklng tlie movement of the virus, and iensitive and speclfic serologic testing enabled the rapid detection and subsequent confirm,~tion of human and equine cases. 4 national database svstem (ArboNET) M-as estahlislied and maintained by CDC to allob,, weekly reportng and updating of W S V sur.ireillance information by all states involved in the sun,eillance, and maps, updated weekly, of the reported information were prepared by the US Geological Survey. Experimental studies of domestic and wild birds revealed that infections in poultry resulted in no clinical disease hut produced some pathologic lesions, whereas clinical disease and 30-50% fatality occurred in domest~c geese. Infected poult^ circulated low amounts of rirus in their blood (viremiai, probably Insufficient to infect mosquitoes, but viremias in young geese were high enough to transinit the virus to mosquitoes. Direct contact transmission between birds did occur with goslings but not M-ith chickens or turkeys. Susceptibilit!-to WK?' infection and clinical disease raned widel!-among irild bird species tested. The American crow, which was suffering the highest natural mortaliti from WNV infections, was also the most susceptible to experimental mniections. Iiearl\-10090 mortalit>-occurred rvithm four to seven days iolloi\,ing inoculation !\.ith a 1999 S e w York strain of MXV virus, and direct transmssion between Lnlected birds and control birds in direct contact bvith each other occurred. Oral transmission of M7NV irom infecred d a n t u.hite mice to crou-s was demonstrited. Viremias in crolas tluoughout the mfeition period were of high titers, making them competent reservoirs to ampiif? transmission, despite their death from the infection. Other ~l l d bird species shoxt~ed similar but less severe responses and were also competent hosts for the virus, whereas some other species were unaffected b! the rirus, simllar in response to domestic poultry. Killed-virus vaccines, including the conditionally licensed WYv7 equine vaccine, were partially successtul in protecting crows from mortality irom experimental \VNV mfection.
The large and rapld geographical expansion oi MYV following its introduction into the contment in 1999 indicates how easily this virulent strain of virus became established, and suggests that it u d l likely continue to spread widely throughout the western hemisphere. following the movements of migratory bird populations. The western states and countries in Central and South America and the Caribbean may soon be iaced with the public and animal health issues of this new arbovirus. In the US human infections wit11 Ih73-V are mostly subclinical and 20% develop mild disease. Less than 1% develop an age-related severe neurological disease, but with a 10 to 14% fatality rate. Less is known about subclinical infections in equines, but clin~cal disease has a rapid onset of staggering, ataxia, and muscle weakness with a 30 to 33% fatality rate. The public health significance for the US has already nearly equaled or cxceeded in 1 years the affect of SLE, wcstcrn equine encephalitis (WEE), and eastern equine encephalitis (EEE)
x-iruses on human lllness for the last 10 years, it has also far exceeded the impact oi IZ'EE and EEE on e q u h e health during the last 10 yea-i even during 2002, in the historica; endemic zone of MTE i n the northern Great Plains states. The health lmpacts of \\'I\' on human and equine populations in Latin America could be more severe because of underlying factors of loxrer nutrition, higher frequency of other diseases and health problems, less health care supp a t , and more exposure to iniected mosquitoes. The massive wild bird mortality associated M-ith VihX is new for the uboviruses and is raising concern among avian biologists as a possible serious threat to the conservation of some migratory and non-migratory avian species. It is hoped that the vlrus activity will shift to an endemic form and that disease outcomes will become less severe.
The contributions of veterinarians to WN\' are obrlous and important, because this is a serious and emerging zoonotic dlsease of wildlife affecting domestic animal and human health over a broad region. Contributions are needed to treating and preventing clinical disease in equines and other animals; to diagnosis; to vaccine development, use, and evaluation; to surveillance; to e p i d e m i o l o~; to fleld and laboratoy investigations of domestic a~m a l s and wildlife;
and to studies on the pathogenesis of the virus.
